EUVIMEDEUVIMED entdecken
Crossref

A Curcumin Analog, 3,5-Bis(2′-ethoxybenzylidene)-piperidine-4-one (E145), Suppresses NF-κB Signaling to Inhibit Breast Cancer Growth and Metastasis

Sana Jabbar, Yue Zhou, Seiya Kobayashi, Ka He, Sisca Ucche, Ritmaleni, So-Ichiro Sasaki, Yoshihiro Hayakawa

Biological and Pharmaceutical Bulletin · 28.07.2026 · 49 (7) · 1174-1181

DOI: 10.1248/bpb.b26-00307 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biological and Pharmaceutical Bulletin, erschienen am 28.07.2026. Verfasst von Sana Jabbar und 7 weiteren Autor:innen. Beteiligte Einrichtung: Section of Host Defences, Institute of Natural Medicine, University of Toyama, Toyama 930-0194, Japan. Hauptthemen laut MEDLINE: Curcumin, Breast Neoplasms, NF-kappa B, Antineoplastic Agents. Die Arbeit nennt 46 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Curcumin is a naturally occurring bioactive compound with well-characterized anti-inflammatory and antitumor properties; however, its clinical utility is limited by poor bioavailability and chemical instability. To overcome these limitations, various curcumin analogs have been developed. In this study, we investigated the antitumor and antimetastatic effects of 3,5-bis(2′-ethoxybenzylidene)-piperidine-4-one (E145), a monocarbonyl curcumin analog, with a particular focus on its ability to inhibit nuclear factor-kappaB (NF-κB) signaling in breast cancer cells. We first evaluated the effects of E145 on cell proliferation in murine 4T1 and human MDA-MB-231 breast cancer cell lines. E145 inhibited cell proliferation in a dose-dependent manner and suppressed phosphorylation of the NF-κB p65 subunit. Furthermore, E145 blocked tumor necrosis factor alpha–induced NF-κB activation by inhibiting both p65 phosphorylation and nuclear translocation. Consistently, E145 reduced the expression of NF-κB–regulated pro-tumorigenic factors, including vascular endothelial growth factor, matrix metalloproteinase-9, interleukin-1β (IL-1β), and IL-6. Functional assays demonstrated that E145 markedly suppressed the migration and invasion of breast cancer cells in vitro. In addition, experimental lung metastasis assays revealed that E145 treatment significantly reduced metastatic colonization of 4T1 cells in vivo. Collectively, these findings indicate that E145 exerts potent antimetastatic effects by inhibiting cell-intrinsic NF-κB activation and downstream inflammatory mediators. These results suggest that E145 is a promising therapeutic candidate for targeting NF-κB–driven breast cancer progression and metastasis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CurcuminBreast NeoplasmsNF-kappa BAntineoplastic AgentsHumansAnimalsFemaleSignal TransductionMDA-MB-231 CellsCell ProliferationCell Line, TumorMiceMice, Inbred BALB CCell MovementLung NeoplasmsPhosphorylationMatrix Metalloproteinase 9Neoplasm Metastasis

Stichwörter der Autor:innen

breast cancercurcumin analogmetastasisnuclear factor-kappaB

Substanzen

CurcuminNF-kappa BAntineoplastic AgentsMatrix Metalloproteinase 9

Autor:innen und Institutionen

  • Section of Host Defences, Institute of Natural Medicine, University of Toyama, Toyama 930-0194, Japan.
  • Department of Cancer Cell Biology, Faculty of Pharmaceutical Sciences, University of Toyama, Toyama 930-0194, Japan.
  • Faculty of Pharmacy, Universitas Gadjah Mada, Yogyakarta 55281, Indonesia.
  • Curcumin Research Center, Faculty of Pharmacy, Universitas Gadjah Mada, Yogyakarta 55281, Indonesia.

Zitieren

APA

Jabbar, S., Zhou, Y., Kobayashi, S., He, K., Ucche, S., Ritmaleni, Sasaki, S. I., & Hayakawa, Y. (2026). A Curcumin Analog, 3,5-Bis(2′-ethoxybenzylidene)-piperidine-4-one (E145), Suppresses NF-κB Signaling to Inhibit Breast Cancer Growth and Metastasis. Biological and Pharmaceutical Bulletin, 49(7), 1174-1181. https://doi.org/10.1248/bpb.b26-00307

Vancouver

Jabbar S, Zhou Y, Kobayashi S, He K, Ucche S, Ritmaleni, et al. A Curcumin Analog, 3,5-Bis(2′-ethoxybenzylidene)-piperidine-4-one (E145), Suppresses NF-κB Signaling to Inhibit Breast Cancer Growth and Metastasis. Biological and Pharmaceutical Bulletin. 2026;49(7):1174-1181. doi:10.1248/bpb.b26-00307

BibTeX
@article{Jabbar2026,
  author = {Jabbar, Sana and Zhou, Yue and Kobayashi, Seiya and He, Ka and Ucche, Sisca and Ritmaleni and Sasaki, So-Ichiro and Hayakawa, Yoshihiro},
  title = {A Curcumin Analog, 3,5-Bis(2′-ethoxybenzylidene)-piperidine-4-one (E145), Suppresses NF-κB Signaling to Inhibit Breast Cancer Growth and Metastasis},
  journal = {Biological and Pharmaceutical Bulletin},
  year = {2026},
  volume = {49},
  number = {7},
  pages = {1174--1181},
  doi = {10.1248/bpb.b26-00307}
}
Kostenlos starten →